Lenvatinib and Peginterferon alfa-2b Subcutaneous
Determining the interaction of Lenvatinib and Peginterferon alfa-2b Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: n.a.
Generic Name: peginterferon alfa-2b
Brand name: PegIntron, Sylatron, PegIntron Redipen
Synonyms: Peginterferon alfa-2b, Peginterferon Alfa-2b
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib-Peginterferon beta-1a
- Lenvatinib-Peginterferon beta-1a Subcutaneous
- Lenvatinib-PegIntron
- Lenvatinib-Pegloticase
- Lenvatinib-Pegloticase Intravenous
- Lenvatinib-Pegvaliase
- Peginterferon alfa-2b Subcutaneous-Lenvatinib Mesylate
- Peginterferon alfa-2b Subcutaneous-Lenvima
- Peginterferon alfa-2b Subcutaneous-Lenvima (14 MG Daily Dose)
- Peginterferon alfa-2b Subcutaneous-Lenvima (18 MG Daily Dose)
- Peginterferon alfa-2b Subcutaneous-Lenvima (20 MG Daily Dose)
- Peginterferon alfa-2b Subcutaneous-Lenvima (24 MG Daily Dose)